凯盛新材：股东华邦健康拟询价转让2000万股，占公司总股本的4.75%

Group 1 - The core point of the article is that Huabang Health plans to transfer 20 million shares of Kaisheng New Materials, accounting for 4.75% of the company's total share capital [1] - The transfer will be conducted through a price inquiry, with the minimum transfer price set at no less than 70% of the average stock trading price over the 20 trading days prior to the issuance of the subscription invitation on July 16, 2025 [1] - The acquiring party must be an institutional investor with appropriate pricing capability and risk tolerance [1] Group 2 - The shares acquired through the inquiry transfer cannot be transferred by the acquiring party within six months after the acquisition [1]